LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 85.42 | 27.76 | 4669 | 7025 | 0.6646 | 0.9002 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 85.42 | 27.76 | 7201 | 7025 | 1.0250 | 1.0062 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 85.42 | 27.76 | 7329 | 7025 | 1.0432 | 1.0106 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 87.13 | 27.76 | 4355 | 6987 | 0.6232 | 0.8849 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 87.13 | 27.76 | 4631 | 6987 | 0.6627 | 0.8995 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 87.13 | 27.76 | 7348 | 6987 | 1.0515 | 1.0126 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 87.13 | 27.76 | 7451 | 6987 | 1.0663 | 1.0162 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 88.84 | 27.76 | 4321 | 6965 | 0.6204 | 0.8837 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 88.84 | 27.76 | 4620 | 6965 | 0.6633 | 0.8996 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 88.84 | 27.76 | 7477 | 6965 | 1.0735 | 1.0179 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 88.84 | 27.76 | 7585 | 6965 | 1.0890 | 1.0215 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 90.55 | 27.76 | 3119 | 6928 | 0.4502 | 0.8093 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 90.55 | 27.76 | 4588 | 6928 | 0.6622 | 0.8991 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 90.55 | 27.76 | 7542 | 6928 | 1.0885 | 1.0214 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 90.55 | 27.76 | 7684 | 6928 | 1.1090 | 1.0262 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 92.25 | 27.76 | 2944 | 6873 | 0.4283 | 0.7977 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 92.25 | 27.76 | 4561 | 6873 | 0.6636 | 0.8995 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 92.25 | 27.76 | 7606 | 6873 | 1.1066 | 1.0256 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 92.25 | 27.76 | 7769 | 6873 | 1.1303 | 1.0310 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 93.96 | 27.76 | 2320 | 6849 | 0.3387 | 0.7453 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 93.96 | 27.76 | 4568 | 6849 | 0.6670 | 0.9006 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 93.96 | 27.76 | 7303 | 6849 | 1.0663 | 1.0162 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 93.96 | 27.76 | 7845 | 6849 | 1.1454 | 1.0345 | MN20160318_Q01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 95.66 | 27.76 | 1445 | 6712 | 0.2153 | 0.6474 | MN20160318_Q01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 95.66 | 27.76 | 4518 | 6712 | 0.6731 | 0.9025 | MN20160318_Q01 | C03 |